Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release May 22 2026
Published 5d ago
5 min read

Press Release May 22 2026

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Levothyroxine Sodium Tablets USP".

View Attachment